Abstract: The present disclosure relates generally to pharmaceutical compositions comprising cannabidiol (CBD), ?-9-tetrahydrocannabinol (THC) and linalool. In some embodiments, the pharmaceutical compositions are useful in the treatment of an inflammatory condition, e.g., useful for the treatment of pain.
Type:
Application
Filed:
December 6, 2021
Publication date:
April 25, 2024
Applicant:
Cymra Life Sciences Limited
Inventors:
Joel Ernest George Hardy, Simon Kenneth Pettinger, John Montgomery, Matthew Turner